[Tree] C3.ai stock performance and software earnings reports

Version 0.17 (2024-12-05 16:50:20.879000)

updates: C3.ai stock rises after positive earnings reports

Version 0.16 (2024-07-14 10:20:13.505000)

updates: Daiwa Securities Group decreases stock holdings

Version 0.15 (2024-07-14 10:19:41.349000)

updates: Stock trading information and analyst ratings

Version 0.14 (2024-07-12 18:07:28.408000)

updates: Highlights C3.ai's strong cash reserves and potential for growth

Version 0.13 (2024-07-06 10:45:59.900000)

updates: C3.ai stock faces potential undervaluation amidst growth cycle

Version 0.12 (2024-07-02 19:10:14.351000)

updates: Being AI reports net loss in full year 2024 earnings

Version 0.11 (2024-07-02 18:52:02.245000)

updates: Integration of Being AI's full year 2024 earnings report

Version 0.1 (2024-06-28 13:15:45.622000)

updates: Integration of analysis on C3.ai's revenue growth and mounting losses

Version 0.09 (2024-06-28 13:04:39.286000)

updates: C3.ai's impressive revenue growth and mounting losses

Version 0.08 (2024-04-02 20:46:56.204000)

updates: Includes information about the decline in C3.ai (NYSE:AI) shares

Version 0.07 (2024-03-26 07:10:12.640000)

updates: Shares of IQ-AI Limited (LON:IQAI) drop in trading

Version 0.06 (2024-03-14 09:19:07.280000)

updates: Shares of Datametrex AI Limited (CVE:DM) dropped 11.1%

Version 0.05 (2024-03-02 19:23:19.670000)

updates: Coverage and ratings for MoonLake Immunotherapeutics

Version 0.04 (2024-03-02 08:25:06.536000)

updates: Analysts issue coverage and ratings for 4D Molecular Therapeutics and Desktop Metal

Version 0.03 (2023-10-28 07:42:02.224000)

updates: Restructured and streamlined information

Version 0.02 (2023-10-20 13:23:30.030000)

updates: Expanded and reorganized information, added details and context

Version 0.01 (2023-10-08 16:07:20.699000)

updates: Combined information about the global HIV Diagnosis Market and the Rare Disease Treatment Market for 2031

Version 0.0 (2023-10-05 13:44:26.528000)

updates: Intact